Therapy News and Research

RSS

Researchers find that human eyes learn best in an uncluttered setting

If athletes, soldiers and drivers must perform every day in visually messy environments, common sense suggests that any visual training they receive should include distractions and disorder.

30 Mar 2005

CDC experts sent to Angola to help with Marburg epidemic

In an effort to control the Marburg virus outbreak in Angola, Health officials from the Centers for Disease Control and Prevention in Atlanta will assist the World Health Organization by going to Angola to help with outbreak investigation, infection control and laboratory diagnosis of the disease.

30 Mar 2005

Primary health care providers should incorporate HIV testing into routine patient care for all sexually active individuals

Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.

30 Mar 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

HIV patients who delay seeking care are much sicker when they begin care

Patients recently diagnosed with human immunodeficiency virus (HIV) are significantly more likely to seek medical treatment if they are followed even briefly by a case manager, according to findings of the national Antiretroviral Treatment Access Study (ARTAS).

30 Mar 2005

Newly emerging illness, named staphylococcal purpura fulminans

Researchers at the University of Minnesota have identified a newly emerging illness, named staphylococcal purpura fulminans. The disease begins as a respiratory tract infection, which then is infected by Staphylococcus aureus.

30 Mar 2005

First North American trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer

Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

30 Mar 2005

Device may offer alternative for stroke patients

As the most common cause of adult disability in the United States, stroke leaves many survivors unable to perform tasks that were once part of their daily routine. Much of the time the disabilities are treatable, but the high cost of rehabilitation therapy leaves many patients to cope on their own.

30 Mar 2005

Exercise may be best treatment for depression

The Mental Health Foundation in it's report - "Up and Running", says exercise might well prove to be a more effective treatment for some forms of depression than pills, and GPs should be offering all patients with depression a programme of exercise to help overcome their symptoms.

29 Mar 2005

Clinical study of mirror neurons provides insights into autism and other disorders

Seeing is doing – at least it is when mirror neurons are working normally. But in autistic individuals, say researchers from the University of California, San Diego, the brain circuits that enable people to perceive and understand the actions of others do not behave in the usual way.

29 Mar 2005

Wolbachia genome reveals new targets to combat infectious disease

More than a billion people are at risk for infection with filarial nematodes, parasites that cause elephantiasis, African river blindness, and other debilitating diseases in more than 150 million people worldwide.

29 Mar 2005

Cells that might be able to suppres cat allergies

In a paper in this month's premier open-access medical journal PLoS Medicine, Mark Larche and colleagues from Imperial College London describe a subset of cells that might be able to suppress cells that cause cat allergy.

29 Mar 2005

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

29 Mar 2005

Poor survival rates in some cancers related to lack of clinical trial participation

In a new study Archie Bleyer, M.D. of the M. D. Anderson Cancer Centre in Houston and colleagues have discovered that mortality and poor survival rates among young adults and older adolescents with some cancers may be explained in part by the lack of participation in clinical trials.

28 Mar 2005

Adult stem cells could be used to treat deaf patients in the future

Researchers at Indiana University School of Medicine are several steps closer to the day when a profoundly deaf patient's own bone marrow cells could be used to let him or her hear the world.

28 Mar 2005

Diffusion MRI gives early indication if brain cancer therapy is effective

A special type of MRI scan that measures the flow of water molecules through the brain can help doctors determine early in the course of brain cancer regimen if a patient's tumor will shrink, a new study shows.

28 Mar 2005

Statins appear to be safe for people with fatty liver disease

Statins appear to be safe for people with fatty liver disease who could benefit from their cholesterol-lowering capabilities, concludes a review paper published in the April 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

28 Mar 2005

Vital molecular step in cell migration

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine.

28 Mar 2005

Important that menopause not viewed as a disease

An independent panel convened last week by the National Institutes of Health found that many women move through the menopausal transition with few disabling symptoms, and that it is important that menopause not be viewed as a disease.

28 Mar 2005

Three different leukemias are all caused by mutations that alter a specific enzyme controlling blood cell proliferation

Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).

28 Mar 2005